Verona Pharma PLC (NASDAQ:VRNA)

4.21
Delayed Data
As of May 22
 -0.09 / -2.09%
Today’s Change
2.01
Today|||52-Week Range
12.89
-26.78%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Verona Pharma PLC have a median target of 16.07, with a high estimate of 50.00 and a low estimate of 5.17. The median estimate represents a +281.67% increase from the last price of 4.21.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Verona Pharma PLC. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.71
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.46%
 
 
 
 
 
 
Growthannually -2.40%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.